Myricx Bio
Healthcare
HQ: London, United Kingdom
Investors: 1
Develops N-myristoyltransferase inhibitors for cancer treatment
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |
Develops N-myristoyltransferase inhibitors for cancer treatment
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |